RoosterBio, Inc.
RoosterBio, Inc. is radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, easier to access, and much simpler to incorporate into product development efforts, leading to a rapid acceleration in products coming to market that incorporate these technologies. Supports over 200 government, academia, institution, and industry partners from more than 25 countries across 6 continents.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2013
About Us
Ushering in the Dawn of a New Day: We solve regenerative medicine product and process development challenges with innovative biomanufacturing strategies.
Your Path to Therapeutic Commercialization
At RoosterBio, we are experts in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry leading quality, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to rapid acceleration in products coming to market that incorporate these technologies.
Research & Optimization
High quality raw materials with built-in processes and protocols make it easy to establish MSCs in new programs.
Product & Process Development
Our complete hMSC systems offer robust and affordable solutions that allow you to focus on your final development goals.
Tech Transfer & Manufacturing
Seamlessly translate into the clinic with off-the-shelf cGMP products and processes that scale alongside you.
Why RoosterBio?
Our Mission: Fuel the Rapid Commercialization of Scalable Regenerative Cures
Our Solutions to Industry Challenges
High-quality MSCs have traditionally been a scarce resource in the field, being expensive and time-consuming to grow, and requiring the skills of highly trained scientists to obtain quality cells. We are driving the transition of MSCs from a scarce resource into an abundant resource, increasing their availability, and decreasing the complexity required to incorporate them into products.
RoosterBio’s translation-friendly products are high volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. We have demonstrated that our cells can be used directly out of thaw – eliminating the expansion step from initiating an experiment. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in regenerative medicine.
Our Collaborators
RoosterBio works side-by-side with regenerative medicine product developers, tissue engineers, cell therapists, and synthetic biologists to advance research and therapies across the globe. We partner our MSC manufacturing expertise and thorough product characterization skills with customers’ and collaborators’ final application or technology.